Please login to the form below

Not currently logged in
Email:
Password:

UK biotech

This page shows the latest UK biotech news and features for those working in and with pharma, biotech and healthcare.

ReNeuron set for recovery after Woodford stake sale

ReNeuron set for recovery after Woodford stake sale

Edison analyst says sale should help shares to stabilise. Shares in UK biotech ReNeuron have been depressed in recent months thanks to a sizeable holding held by the now-defunct Woodford

Latest news

  • It’s Brexit day – now comes the really hard stuff It’s Brexit day – now comes the really hard stuff

    It’s worth noting that despite the disruption caused by the build-up to Brexit, the UK’s biopharma sector enjoyed one of its most successful years in 2019. ... UK biotech’s raised £1.3bn in financing, the third best year for the sector behind 2018

  • UK biotech funding falls 40% between 2018 and 2019 UK biotech funding falls 40% between 2018 and 2019

    Drop attributed to global uncertainty and Neil Woodford scandal. After a record-breaking year for UK biotech in 2018, the UK BioIndustry Association has revealed overall investment fell to £1.3bn ... country. “The UK biotech sector continues to chart

  • Merck strengthens KRAS stake with Taiho and Astex partnership Merck strengthens KRAS stake with Taiho and Astex partnership

    Partner companies could gain $2.5bn in milestone payments. Merck &Co/MSD has announced a partnership with Otsuka's Taiho unit and Cambridge, UK-based biotech Astex Pharmaceuticals for the development

  • UK biotech Evgen craters on failed stroke trial UK biotech Evgen craters on failed stroke trial

    Shares in the biotech more than halved following the news. Evgen Pharma says it is ‘unlikely’ to continue development of its lead drug in haemorrhagic stroke after it failed a phase ... News of the disappointing results in the SAS trial of SFX-01

  • UK immunology biotech MiroBio launches with $34m fundraising UK immunology biotech MiroBio launches with $34m fundraising

    The new biotech is focused on the development of therapeutic antibodies that can “reapply the natural brakes” of the immune system that are faulty in auto-immune diseases. ... Stein is also senior R&D advisor to US biotech Agenus, having served as

More from news
Approximately 25 fully matching, plus 155 partially matching documents found.

Latest Intelligence

  • A snapshot of Healx A snapshot of Healx

    Healx is based in Cambridge, UK, a key European biotech hub, and was founded in 2014 by Dr Tim Guilliams, a biochemical engineer and founder of the Cambridge Rare Disease Network, ... Why will the company make it in the high-risk, highly competitive

  • A snapshot of Microbiotica A snapshot of Microbiotica

    Why will Microbiotica make it in the high-risk, highly competitive biotech field? ... Of greater concern is the university sector – the UK biotech sector is what it is because of the increasing excellence of the university sector over the last 20 years.

  • Building European biotech firms to rival those of the US Building European biotech firms to rival those of the US

    Richard Mason (pictured above) is a veteran of the UK biotech industry, including a spell as CEO of company XO1 set up by venture capital investors Index Ventures (now Medicxi) in ... In the early days of UK biotech, this often led to major upfront

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    How can the UK life science ecosystem produce even more biotech start-ups, and propel them to long-term success? ... Its founding investors include Cambridge Innovation Capital, Babraham Research Campus through Babraham Bioscience Technologies, Roche's

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    genetic research through to drug development in pharma, and into leadership of several successful UK biotech firms. ... That’s why Theodora Hall taking on the top job at emerging UK biotech Crescendo Biologics is worth noting, as she represents a new

More from intelligence
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest appointments

  • F-star hires ex-BMS immuno-oncology leader

    New CMO to oversee development of lead candidate. UK biotech F-star has appointed Louis Kayitalire, MD, as its new Chief Medical Officer (CMO), wooing him from a senior role in ... F-star says this newly created management position will be crucial

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Latest movers in pharma and biotech. Immunocore names new CEO. Bahija Jallal, Immunocore's next CEO. ... Immunotherapy-focused UK biotech company Immunocore has unveiled Bahija Jallal as its new chief executive and director of the board.

  • Redx poaches AstraZeneca senior executive Redx poaches AstraZeneca senior executive

    Lisa Anson joins the UK biotech as its CEO. Drug discovery and development group Redx Pharma has appointed its new chief executive officer in the form of Lisa Anson. ... substantial biotech company built upon an innovative science base, selectively

  • Redx Pharma appoints new chief medical officer Redx Pharma appoints new chief medical officer

    Dr Andrew Saunders joins the UK biotech from Lytix Biopharma. Drug discovery and development group Redx Pharma has appointed Dr Andrew Saunders as its chief medical officer (CMO), a role that ... He joins the UK biotech from Lytix Biopharma, a Norweigan

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Dr Robert Lutz and Dr Jon Roffey join the UK biotech. ... Glythera has appointed new chief scientific officer Dr Robert Lutz to lead the advancement of the UK-based biotech's antibody drug conjugate portfolio.

More from appointments
Approximately 2 fully matching, plus 27 partially matching documents found.

Latest from PMHub

  • Lucid bolsters its senior leadership team

    Shula began working in medical communications in the USA following a successful research career in academia and the biotech industry in the UK, Germany and the USA. ... Coming back to the UK after 13 happy and successful years in America has given me the

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics